| A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients (NCT01242215) | Astellas Pharma Inc | 2010-09-17 |
| A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients (NCT01225081) | Astellas Pharma Inc | 2010-09-15 |
| Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus (NCT01224366) | Novartis | 2010-09-01 |
| A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2 (NCT01197963) | The University of Texas Health Science Center, Houston | 2010-09-01 |
| Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin (NCT01175408) | Endocrine Research Society | 2010-09-01 |
| Hypoglycemia: Physician and Patient Perspectives (NCT01176656) | AstraZeneca | 2010-09-01 |
| A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients (NCT01221519) | AstraZeneca | 2010-09-01 |
| Vinegar Co-ingestion in Type 2 Diabetes (NCT01279317) | Maastricht University Medical Center | 2010-09-01 |
| Effect of Pioglitazone on Testosterone in Eugonadal Men With Type 2 Diabetes Mellitus - A Pilot Study (NCT01206400) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2010-09-01 |
| Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251) (NCT01189890) | Merck Sharp & Dohme LLC | 2010-08-16 |
| Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis (NCT01254552) | Guerbet | 2010-08-01 |
| Type 2 Diabetes Mellitus Collaborative Genetic Study on Non-aboriginal Taiwanese (NCT01250639) | China Medical University Hospital | 2010-08-01 |
| The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes (NCT01181986) | Carl T. Hayden VA Medical Center | 2010-08-01 |
| Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes (NCT01175473) | Sanofi | 2010-08-01 |
| Stem Cell Therapy for Type 2 Diabetes Mellitus (NCT01142050) | Cellonis Biotechnology Co. Ltd. | 2010-08-01 |
| Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT01165268) | AstraZeneca | 2010-08-01 |
| Type 2 Diabetes Mellitus and Atherosclerosis (NCT01250340) | University of Roma La Sapienza | 2010-08-01 |
| Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy (NCT01444248) | Handok Inc. | 2010-08-01 |
| Type 2 Diabetes and Obesity in Mexican Pimas: Gene-Environment Interaction (NCT01168297) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2010-07-06 |
| NOX-E36 Multiple Ascending Dose Study in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus (NCT01085292) | TME Pharma AG | 2010-07-01 |
| Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients (NCT02786979) | Astellas Pharma Inc | 2010-07-01 |
| Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin (NCT01169779) | Sanofi | 2010-07-01 |
| Comparing Internet Blood Glucose Monitoring System and Continuous Glucose Monitoring System (NCT01162694) | Endocrine Research Society | 2010-07-01 |
| Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus (NCT02024971) | Takeda | 2010-07-01 |
| Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262) (NCT01340768) | Merck Sharp & Dohme LLC | 2010-06-22 |
| Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus (NCT01144338) | AstraZeneca | 2010-06-18 |
| A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229) (NCT01076075) | Merck Sharp & Dohme LLC | 2010-06-03 |
| The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes (NCT01404676) | Samsung Medical Center | 2010-06-01 |
| Register for Patients With Diabetic Foot Syndrome and Critical Limb Ischemia (NCT01599442) | GWT-TUD GmbH | 2010-06-01 |
| Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus (NCT01154348) | Shionogi | 2010-06-01 |
| The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 Diabetes (NCT01420692) | Ankara University | 2010-06-01 |
| The Effect of Non-Surgical Periodontal Therapy on Glycemic Control and Bacterial Levels in a Mexican-American Population With Type 2 Diabetes (NCT01128374) | The University of Texas Health Science Center, Houston | 2010-06-01 |
| A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients (NCT01135433) | Astellas Pharma Inc | 2010-05-15 |
| Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202) (NCT00993187) | Merck Sharp & Dohme LLC | 2010-05-04 |
| Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin (NCT01422590) | Samsung Medical Center | 2010-05-01 |
| Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes (NCT01206322) | Beth Israel Deaconess Medical Center | 2010-05-01 |
| Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease (NCT01108978) | Nang Kuang Pharmaceutical Co., Ltd. | 2010-05-01 |
| Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications (NCT01107886) | AstraZeneca | 2010-05-01 |
| Study of the Safety and Biologic Activity of XOMA 052 in Subjects With Type 2 Diabetes Mellitus (NCT01144975) | XOMA (US) LLC | 2010-05-01 |
| The Role of Vitamin D3 and Calcium Supplementation in Attenuating T2DM Severity (NCT02464462) | York University | 2010-05-01 |
| A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403 (NCT01131091) | Kowa Research Institute, Inc. | 2010-05-01 |
| Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin (NCT01106131) | Chong Kun Dang Pharmaceutical | 2010-05-01 |
| Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus (NCT01137695) | Cheryl Rosenfeld, DO | 2010-05-01 |
| Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in Type 2 Diabetes Mellitus (NCT01107132) | Soroka University Medical Center | 2010-05-01 |
| Development of a Fast Measurement Technique of Insulin Resistance in Human (NCT01493934) | Institut National de la Santé Et de la Recherche Médicale, France | 2010-04-01 |
| YKL-40 and Complications in Type 2 Diabetes (NCT01387984) | National Taiwan University Hospital | 2010-04-01 |
| Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients (NCT01103609) | AstraZeneca | 2010-04-01 |
| An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor (NCT01112696) | Medtronic MiniMed, Inc. | 2010-04-01 |
| Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases (NCT01337440) | Kanazawa University | 2010-04-01 |
| ET-blockade and Exercise-induced Vascular Adaptations in T2DM (NCT01779609) | Radboud University Medical Center | 2010-04-01 |
| Effect of Exenatide on Liver and Heart Fat and Inflammation (NCT01951651) | Baylor College of Medicine | 2010-04-01 |
| Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without Pottasium (NCT01404078) | St. John's Research Institute | 2010-04-01 |
| Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants (NCT01068717) | AstraZeneca | 2010-03-01 |
| Studies Investigating Co-morbidities Aggravating Heart Failure (NCT01872299) | Charite University, Berlin, Germany | 2010-03-01 |
| Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease (NCT01042977) | AstraZeneca | 2010-03-01 |
| Study To Assess the Pharmacokinetics of AZD1656 During Coadministration With Simvastatin (NCT01096940) | AstraZeneca | 2010-03-01 |
| Effects of Physical Exercise in Type 2 Diabetics (NCT01095068) | University Hospital, Strasbourg, France | 2010-03-01 |
| Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus (NCT01095991) | AstraZeneca | 2010-03-01 |
| Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM) (NCT01196546) | Novartis | 2010-03-01 |
| Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects (NCT01068756) | AstraZeneca | 2010-03-01 |
| To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656 (NCT01083212) | AstraZeneca | 2010-03-01 |
| Soluble Dietary Fibres in the Prevention of Type 2 Diabetes Mellitus (NCT01163006) | Maastricht University Medical Center | 2010-03-01 |
| A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal Impairment (NCT01097681) | Astellas Pharma Inc | 2010-02-16 |
| Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered (NCT01068743) | AstraZeneca | 2010-02-01 |
| A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus (NCT01044537) | Pfizer | 2010-02-01 |
| A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers (NCT01088594) | Solvay Pharmaceuticals | 2010-02-01 |
| Evidence-Based Nutrition Practice Guidelines of Toolkit and Preliminary Outcomes (NCT04311853) | Academy of Nutrition and Dietetics | 2010-02-01 |
| Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects (NCT01068730) | AstraZeneca | 2010-02-01 |
| Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM) on Combination Oral Therapy (NCT01060241) | Endocrine Research Society | 2010-02-01 |
| Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension (NCT01031680) | AstraZeneca | 2010-02-01 |
| Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans (NCT01681693) | University of California, San Francisco | 2010-02-01 |
| Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4? (NCT01040819) | Baylor College of Medicine | 2010-02-01 |
| Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus (NCT01082120) | AstraZeneca | 2010-02-01 |
| To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies (NCT01068860) | Novartis | 2010-02-01 |
| Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus (NCT01072331) | Tanabe Pharma Corporation | 2010-02-01 |
| A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients (NCT01054092) | Astellas Pharma Inc | 2010-01-14 |
| A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients (NCT01057628) | Astellas Pharma Inc | 2010-01-13 |
| Effect of Oral Administration of a Herbarium Mixture (Guazuma Ulmifolia and Tecoma Stans) on Metabolic Profile in Type 2 Diabetic Patients (NCT03313856) | Centro Universitario de Ciencias de la Salud, Mexico | 2010-01-10 |
| The Effect of Prostaglandin I2 on the Endothelial Cell Function Disorder in Type 2 Diabetes Mellitus Patients (NCT01061060) | Yonsei University | 2010-01-01 |
| Risk Prediction in Type II Diabetics With Ischemic Heart Disease (NCT01422057) | Thebiosignals.com | 2010-01-01 |
| Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM) on Monotherapy (NCT01044368) | Endocrine Research Society | 2010-01-01 |
| Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 Diabetes (NCT01073020) | Joslin Diabetes Center | 2010-01-01 |
| Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients (NCT01055652) | AstraZeneca | 2010-01-01 |
| Caloric Restriction and Insulin Secretion (NCT01447524) | University of Rome Tor Vergata | 2010-01-01 |
| Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D (NCT02607410) | University of Sao Paulo General Hospital | 2010-01-01 |
| Effect of Incretin-related Drugs on Dietary Intake in Japanese Patients With Type 2 Diabetes Mellitus (NCT01568125) | Nagaoka Red Cross Hospital | 2010-01-01 |
| A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus (NCT01028963) | Amgen | 2010-01-01 |
| Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines (NCT06355219) | Ali Aminian | 2010-01-01 |
| Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes (NCT01029886) | AstraZeneca | 2010-01-01 |
| Pilot Study Of The Effects Of Resveratrol On Endothelial Function In Subjects With Type 2 Diabetes Mellitus (NCT01038089) | Boston University | 2010-01-01 |
| Influence of DPP-4 on Inflammatory Parameters in Diabetics: Gender Aspects (NCT01162772) | Medical University of Vienna | 2010-01-01 |
| Managing Diabetes During Pregnancy in the Wireless Age (NCT01474525) | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | 2010-01-01 |
| Metabolic Surgery Versus Medical Management for Resolution of Type II Diabetes (NCT01044602) | David Bradley MD | 2010-01-01 |
| Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy (NCT01066715) | XOMA (US) LLC | 2010-01-01 |
| Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes (NCT01602003) | LG Life Sciences | 2009-12-01 |
| Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes (NCT01601990) | LG Life Sciences | 2009-12-01 |
| Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes (NCT01026194) | Tanabe Pharma Corporation | 2009-12-01 |
| A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus (NCT01023945) | Astellas Pharma Inc | 2009-11-07 |
| Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus-2 (NCT01065298) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2009-11-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy Adults (NCT01042106) | Sumitomo Pharma America, Inc. | 2009-11-01 |